Literature DB >> 10739090

The key role of butyrylcholinesterase during neurogenesis and neural disorders: an antisense-5'butyrylcholinesterase-DNA study.

A Mack1, A Robitzki.   

Abstract

The wide tissue distribution of butyrylcholinesterase (BChE) in organisms makes specific roles possible, although no clear physiologic function has yet been assigned to this enzyme. In vertebrates, it appears e.g. in serum, hemopoietic cells, liver, lung, heart, at cholinergic synapses, in the central nervous system. in tumors and not at least (besides acetylcholinesterase, AChE) in developing embryonic tissues. Here, a functional role of BChE can be found in regulation of cell proliferation and the onset of differentiation during early neuronal development--independent of its enzymatic activity. For studies concerning this point, we have established a strategy for a specific and efficient inhibition of BChE to investigate how the expected decrease of enzyme and, therefore, the manipulation of cellular cholinesterase-equilibrium influences embryonic neurogenesis--among others to gain information about the significance of noncholinergic, activity-independent and cell growth functions of BChE. The antisense-5'BChE-DNA strategy is based on inhibition of BChE mRNA transcription and protein synthesis. For this, the BChE gene is cloned into a suitable vector system; this is done in antisense-orientation, so that a transfected cell will produce their own antisense mRNA to inhibit gene expression. For such investigations in neurogenesis, the developing retina is a good model and we are able to create organotypic, three-dimensional retinal aggregates in vitro (retinospheroids) using isolated retinal cells of 6-day-old chicken embryos. Using this in vitro retina and "knock out" of BChE gene expression, we could show a key role of BChE during neurogenesis. The results are of great interest because in tumorigenesis and some neuronal disorders, the BChE gene is amplified or abnormally expressed. It has to be discussed how the antisense-5'BChE strategy can play a role in the development of new and efficient therapy forms.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10739090     DOI: 10.1016/s0301-0082(99)00047-7

Source DB:  PubMed          Journal:  Prog Neurobiol        ISSN: 0301-0082            Impact factor:   11.685


  21 in total

Review 1.  Bacterial cocaine esterase: a protein-based therapy for cocaine overdose and addiction.

Authors:  Diwahar Narasimhan; James H Woods; Roger K Sunahara
Journal:  Future Med Chem       Date:  2012-02       Impact factor: 3.808

2.  Design, preparation, and characterization of high-activity mutants of human butyrylcholinesterase specific for detoxification of cocaine.

Authors:  Liu Xue; Mei-Chuan Ko; Min Tong; Wenchao Yang; Shurong Hou; Lei Fang; Junjun Liu; Fang Zheng; James H Woods; Hsin-Hsiung Tai; Chang-Guo Zhan
Journal:  Mol Pharmacol       Date:  2010-10-22       Impact factor: 4.436

3.  Cholinesterase activity on Echinogammarus meridionalis (Pinkster) and Atyaephyra desmarestii (Millet): characterisation and in vivo effects of copper and zinc.

Authors:  C Quintaneiro; M Monteiro; A M V M Soares; J Ranville; A J A Nogueira
Journal:  Ecotoxicology       Date:  2014-02-14       Impact factor: 2.823

Review 4.  Pharmacodynamic-tolerability relationships of cholinesterase inhibitors for Alzheimer's disease.

Authors:  B P Imbimbo
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

5.  Reduction of butyrylcholinesterase activity in rat serum subjected to hyperhomocysteinemia.

Authors:  Francieli M Stefanello; Renata Franzon; Bárbara Tagliari; Clovis Wannmacher; Moacir Wajner; Angela T S Wyse
Journal:  Metab Brain Dis       Date:  2005-06       Impact factor: 3.584

6.  Pharmacophore-based virtual screening and density functional theory approach to identifying novel butyrylcholinesterase inhibitors.

Authors:  Sugunadevi Sakkiah; Keun Woo Lee
Journal:  Acta Pharmacol Sin       Date:  2012-06-11       Impact factor: 6.150

7.  Pressure- and heat-induced inactivation of butyrylcholinesterase: evidence for multiple intermediates and the remnant inactivation process.

Authors:  A Weingand-Ziade; F Ribes; F Renault; P Masson
Journal:  Biochem J       Date:  2001-06-01       Impact factor: 3.857

8.  Homocysteine inhibits butyrylcholinesterase activity in rat serum.

Authors:  Francieli M Stefanello; Alexandra I Zugno; Clovis M D Wannmacher; Moacir Wajner; Angela T S Wyse
Journal:  Metab Brain Dis       Date:  2003-09       Impact factor: 3.584

9.  Arginine administration decreases cerebral cortex acetylcholinesterase and serum butyrylcholinesterase probably by oxidative stress induction.

Authors:  Angela T S Wyse; Francieli M Stefanello; Fábria Chiarani; Débora Delwing; Clóvis M D Wannmacher; Moacir Wajner
Journal:  Neurochem Res       Date:  2004-02       Impact factor: 3.996

10.  In vitro homocysteine inhibits platelet Na+,K+-ATPase and serum butyrylcholinesterase activities of young rats.

Authors:  Francieli M Stefanello; Renata Franzon; Clovis M D Wannmacher; Moacir Wajner; Angela T S Wyse
Journal:  Metab Brain Dis       Date:  2003-12       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.